Prot #RVT-2301-201: A Phase 2, Randomized, Placebo-Controlled Trial to Assess the Efficacy and Safety of Mosliciguat in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease

Project: Research project

Project Details

StatusActive
Effective start/end date11/7/2411/7/27

Funding

  • Ice Global Consulting, Inc. (Prot #RVT-2301-201 // Prot #RVT-2301-201)
  • Pulmovant, Inc. (Prot #RVT-2301-201 // Prot #RVT-2301-201)